Aptus Capital Advisors’s Sanofi SNY Stock Holding History

Aptus Capital Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$201K	Buy	+4,703	New	+$210K	﹤0.01%	1117
2025 Q3	–	Sell	-4,761	Closed	-$230K	–	1653
2025 Q2	$230K	Buy	4,761 +1,088	+30%	+$55.6K	﹤0.01%	901
2025 Q1	$204K	Buy	+3,673	New	+$199K	﹤0.01%	887
2024 Q4	–	Sell	-3,792	Closed	-$219K	–	1455
2024 Q3	$219K	Sell	3,792 -426	-10%	-$23K	﹤0.01%	739
2024 Q2	$205K	Buy	+4,218	New	+$203K	﹤0.01%	731
2019 Q2	–	Sell	-4,790	Closed	-$212K	–	361
2019 Q1	$212K	Buy	+4,790	New	+$205K	0.04%	294

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Aptus Capital Advisors's SNY Position: Q2 2026 in Review

Aptus Capital Advisors opened a new position in Sanofi (SNY) in Q2 2026: 4,703 shares worth $201K. The stake represents ﹤0.01% of the portfolio and ranks #1117 among its holdings. This is a return to the name: Aptus Capital Advisors previously reported a position in SNY as recently as Q2 2025.

Aptus Capital Advisors first reported a position in SNY in Q1 2019 and has held it in 6 quarters since. The position peaked at $230K in Q2 2025. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Aptus Capital Advisors held 4,703 shares of Sanofi worth $201K as of Q2 2026.
Sanofi was a new Aptus Capital Advisors position in Q2 2026.
Sanofi made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #1117 holding.
Aptus Capital Advisors first reported a position in Sanofi in Q1 2019 and has held it in 6 quarters since.
Aptus Capital Advisors's Sanofi position peaked at $230K in Q2 2025.
716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.